Located in the heart of the Central Business District, the New Orleans BioInnovation Center (NOBIC) is a private, not-for-profit business incubator supporting entrepreneurship and the development of bioscience innovation throughout Louisiana. The Center offers 66,000 square feet of state-of-the-art wet-lab, office, and conference space to conceive and cultivate new bioscience ideas.

NOBIC currently houses more than 30 companies and works directly with entrepreneurs and researchers to commercialize new technologies and to start and scale new, globally competitive life sciences companies.

Ochsner Health is Louisiana’s largest healthcare system, providing coordinated clinical and hospital patient care across the region through Ochsner’s 40 owned, managed, and affiliated hospitals and specialty hospitals and 100+ health centers and urgent care centers.

In addition to its clinical services, Ochsner is leading the charge into the next frontier of healthcare with innovationOchsner (iO), a lab using technology and data to create precision-focused, patient-centered solutions to keep patients healthier and make providers more efficient. iO launched in 2015 with the goal of reimagining the delivery and experience of healthcare in a way that enhances quality, access, patient satisfaction and engagement, and lowers costs.

LCMC is a New Orleans-based, nonprofit health system founded by the state’s only freestanding children’s hospital. Today, LCMC Health consists of Children’s Hospital, Touro, University Medical Center New Orleans, East Jefferson General Hospital, New Orleans East Hospital, and West Jefferson Medical Center, in addition to a network of urgent care centers. LCMC employs nearly 10,000 clinicians and professionals and partners with local universities to help train thousands of medical, dentistry, nursing, and allied health students in LCMC hospitals every year.

AxoSim was founded to address unsustainably high clinical failure rates that cost pharmaceutical companies billions of dollars and patients years of waiting for new medications and therapies for serious neurological diseases. The company spun out of Tulane University in 2014 with a license to proprietary technology and the potential to solve the challenge of modeling human results in vitro.

Today, AxoSim’s Nerve-on-a-Chip® and Mini-Brain platforms are revolutionizing the way that biopharmaceutical companies develop neurological drugs. AxoSim’s growing team of scientists, technicians, operations people, and more are making changes for patients while working in a vibrant, entrepreneurial, collaborative, and innovative atmosphere.